Aigen Investment Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-23,207
Closed -$1.08M 1132
2020
Q3
$1.08M Sell
23,207
-11,725
-34% -$403K 0.14% 237
2020
Q2
$1.26M Buy
34,932
+6,004
+21% +$221K 0.16% 192
2020
Q1
$1.03M Buy
28,928
+26,494
+1,088% +$1.08M 0.14% 206
2019
Q4
$111K Buy
+2,434
New +$88.4K 0.02% 665

Other funds holding ZYME

Aigen Investment Management's ZYME Position: Q4 2020 in Review

Aigen Investment Management sold out of Zymeworks (ZYME) in Q4 2020, closing a stake of 23,207 shares — an estimated $1.08M sold.

Aigen Investment Management first reported a position in ZYME in Q4 2019 and held it in 4 quarters. The position peaked at $1.26M in Q2 2020. 138 funds tracked by Wall St. Rank hold ZYME as of Q4 2020.

  • Aigen Investment Management reported no remaining Zymeworks position as of Q4 2020 after selling out during the quarter.
  • Aigen Investment Management sold 23,207 Zymeworks shares in Q4 2020, an estimated $1.08M.
  • Aigen Investment Management first reported a position in Zymeworks in Q4 2019 and held it in 4 quarters.
  • Aigen Investment Management's Zymeworks position peaked at $1.26M in Q2 2020.
  • 138 funds tracked by Wall St. Rank held Zymeworks as of Q4 2020.

Based on Aigen Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.